Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedservRegisMAL:MDS 42 Return-on-Tangible-Equity is 10.44% as of Dec. 2025. GuruFocus rates MAL:MDS with a GF Score™ of 42/100 and a GF Value™ of €0.92 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 942 Oil & Gas companies, MedservRegis ranks better than 64.01% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. MedservRegis's annualized net income for the quarter that ended in Dec. 2025 was €4.5 Mil. MedservRegis's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €43.1 Mil. Therefore, MedservRegis's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 10.44%.
The historical rank and industry rank for MedservRegis's Return-on-Tangible-Equity or its related term are showing as below:
MAL:MDS'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -90.71 Med: -8.6 Max: 30.95
Current: 12.11
During the past 13 years, MedservRegis's highest Return-on-Tangible-Equity was 30.95%. The lowest was -90.71%. And the median was -8.60%.
MAL:MDS's Return-on-Tangible-Equity is ranked better than 64.01% of 942
companies
in the Oil & Gas industry
Industry Median: 6.77
vs MAL:MDS: 12.11
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
MedservRegis Return-on-Tangible-Equity Related Terms
MedservRegis Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for MedservRegis's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAL:MDS vs SLB, BKR, HAL: Return-on-Tangible-Equity Comparison
For the Oil & Gas Equipment & Services subindustry, MedservRegis's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedservRegis Return-on-Tangible-Equity vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, MedservRegis's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where MedservRegis's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 10.44% mean?
MedservRegis (MAL:MDS) has a Return-on-Tangible-Equity of 10.44% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MedservRegis and its competitors. According to the industry distribution chart, MedservRegis ranks #339 out of 942 companies in the Oil & Gas industry, placing it in the top 36%.
Is MedservRegis' Return-on-Tangible-Equity too high?
MedservRegis' current Return-on-Tangible-Equity is 10.44%. The Oil & Gas industry median Return-on-Tangible-Equity is 6.77. MedservRegis' value of 10.44% is 54.2% above this industry median. Based on the distribution chart, MedservRegis ranks #339 out of 942 companies in the Oil & Gas industry, which is above the industry midpoint. Overall, MedservRegis has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MedservRegis' Return-on-Tangible-Equity compare to SLB and BKR?
According to the Oil & Gas industry distribution chart, MedservRegis ranks #339 out of 942 companies for Return-on-Tangible-Equity. This puts MedservRegis in the upper half of its industry. The industry median Return-on-Tangible-Equity is 6.77. MedservRegis' value of 10.44% is 54.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for an Oil & Gas company?
The median Return-on-Tangible-Equity among Oil & Gas companies is 6.77, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedservRegis's current Return-on-Tangible-Equity of 10.44% is 54.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MedservRegis and its competitors. For the Oil & Gas industry, the median Return-on-Tangible-Equity is 6.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedservRegis's current Return-on-Tangible-Equity is 10.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedservRegis stock overvalued right now?
Based on GuruFocus' analysis, MedservRegis (MAL:MDS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.92, compared to a current price of €0.69 — trading 25% below its estimated fair value. The current Return-on-Tangible-Equity is 10.44% and 54.2% above the Oil & Gas industry median of 6.77. MedservRegis' overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For MedservRegis (MAL:MDS), the current Return-on-Tangible-Equity is 10.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedservRegis (MAL:MDS) Overvalued in 2026?
Based on GuruFocus' analysis, MedservRegis stock appears to be undervalued.
The current stock price of €0.69 is trading 25% below its estimated GF Value™ of €0.92.
GuruFocus considers MedservRegis to be Modestly Undervalued.
Key valuation signals for MAL:MDS:
Return-on-Tangible-Equity: 10.44%
GF Value™: €0.92 vs. price of €0.69 (25% below fair value)
Industry Position: 54.2% above the Oil & Gas median (#339 of 942)
No single metric tells the full story. See the MAL:MDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedservRegis PLC is engaged in providing shore-based logistics to the offshore oil and gas industry and engineering and supply chain management for oil country tubular goods (OCTG) to support the onshore oil and gas industry. Its segment includes Integrated logistics support services; Oil country tubular goods; Trading activity and Photovoltaic farms. The company generates maximum revenue from the Integrated logistics support services segment, that Includes the provision of comprehensive logistical support services to the offshore oil and gas industry from the group's bases in Malta, Cyprus, Egypt, South America, and Africa.
42GF Score
Get the complete analysis for MAL:MDS
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAL:MDS has been successfully added to your 
